Search research articles
Contact Us
Filters
Showing results (11-20 of 259) with videos related to
Page
of 26
Sort By:
European Heart Journal
|
October 4, 2016
Cardiovascular side effects of small molecule therapies for cancer
Shawn C Pun, Tomas G Neilan
JACC. Heart Failure
|
March 5, 2020
Reply: Death, Heart Failure, and HIV: Have We Got it the Wrong Way Around?
Raza M Alvi, Tomas G Neilan
European Heart Journal
|
December 8, 2020
Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?
Matthias Totzeck, Esther Lutgens, Tomas G Neilan
European Heart Journal
|
August 30, 2022
Cardiovascular complications of immune checkpoint inhibitors for cancer
Franck Thuny, Jarushka Naidoo, Tomas G Neilan
Cardiology Clinics
|
October 8, 2019
Cardiotoxicity of Immune Therapy
Sarju Ganatra, Rohan Parikh, Tomas G Neilan
Journal of the American College of Cardiology
|
December 3, 2014
Obstructive sleep apnea and atrial fibrillation: is the link real?
Atul Malhotra, Tomas G Neilan, Kathleen Sarmiento
Journal of the American College of Cardiology
|
July 23, 2021
Reply: Imaging Edema in Immune Checkpoint Inhibitor Myocarditis: A Moving Target
Paaladinesh Thavendiranathan, Lili Zhang, Tomas G Neilan
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 15, 2021
Call on the reserve: Coronary vasomotor dysfunction is a potential biomarker of cardiovascular risk in patients with breast cancer
Michael T Osborne, Simran Grewal, Tomas G Neilan
Current HIV/AIDS Reports
|
September 5, 2019
Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations
Mabel Toribio, Tomas G Neilan, Markella V Zanni
Blood
|
February 24, 2023
How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapy
Cristina Gutierrez, Tomas G Neilan, Natalie S Grover
Page
of 26
Search research articles
Search
Showing results (11-20 of 259) with videos related to
Sort By:
Page
of 26
European Heart Journal
|
October 4, 2016
Cardiovascular side effects of small molecule therapies for cancer
Shawn C Pun, Tomas G Neilan
JACC. Heart Failure
|
March 5, 2020
Reply: Death, Heart Failure, and HIV: Have We Got it the Wrong Way Around?
Raza M Alvi, Tomas G Neilan
European Heart Journal
|
December 8, 2020
Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?
Matthias Totzeck, Esther Lutgens, Tomas G Neilan
European Heart Journal
|
August 30, 2022
Cardiovascular complications of immune checkpoint inhibitors for cancer
Franck Thuny, Jarushka Naidoo, Tomas G Neilan
Cardiology Clinics
|
October 8, 2019
Cardiotoxicity of Immune Therapy
Sarju Ganatra, Rohan Parikh, Tomas G Neilan
Journal of the American College of Cardiology
|
December 3, 2014
Obstructive sleep apnea and atrial fibrillation: is the link real?
Atul Malhotra, Tomas G Neilan, Kathleen Sarmiento
Journal of the American College of Cardiology
|
July 23, 2021
Reply: Imaging Edema in Immune Checkpoint Inhibitor Myocarditis: A Moving Target
Paaladinesh Thavendiranathan, Lili Zhang, Tomas G Neilan
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 15, 2021
Call on the reserve: Coronary vasomotor dysfunction is a potential biomarker of cardiovascular risk in patients with breast cancer
Michael T Osborne, Simran Grewal, Tomas G Neilan
Current HIV/AIDS Reports
|
September 5, 2019
Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations
Mabel Toribio, Tomas G Neilan, Markella V Zanni
Blood
|
February 24, 2023
How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapy
Cristina Gutierrez, Tomas G Neilan, Natalie S Grover
Page
of 26